Curation
PascalFrancis
Racine
Curation
Checkpoint
PascalFrancis
Racine
PascalFrancis
Exploration
Accueil
Racine
Racine

La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities

Identifieur interne : 000599 ( PascalFrancis/Curation ); précédent : 000598; suivant : 000600

A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities

Auteurs : Murray M. Finkelstein [Canada] ; Michael Jerrett [États-Unis]

Source :

RBID : Pascal:07-0357748

Descripteurs français

English descriptors

Abstract

There is concern that industrial emissions of manganese (Mn) and the use of Mn-containing compounds as fuel additives might increase the population risk of Parkinson's disease (PD)-like disorders. We investigated associations between the diagnosis and treatment of PD and markers of exposure to vehicle exhaust and industrial emissions of Mn within a cohort of 110,000 subjects in the cities of Toronto and Hamilton, Canada. Methylcyclopentadienyl manganese tricarbonyl (MMT) has been added to Canadian gasoline since 1976 and steelmaking in Hamilton emits Mn to the air. Using residential postal codes, subjects were mapped to: (1) residence locations close to traffic and to neighbourhood levels of NO2, as markers of traffic-generated air pollution (TGAP); and, (2) neighbourhood levels of ambient Mn in Hamilton, as measured by the Mn fraction of total suspended particulate. Subjects were linked to Ministry of Health administrative databases, 1992-1999, to identify physicians' diagnoses of PD and prescriptions for L-Dopa containing medications. In Toronto, we found no association between PD and the markers of TGAP. In Hamilton, the odds ratio for a physician's diagnosis of PD was 1.034 (1.00-1.07) per 10 ng/m3 increase in Mn in TSP. The estimate of the "doubling exposure" for physician-diagnosed PD was about 150 ng/m3 Mn in TSP. Examination of prevalence curves suggested that exposure to ambient Mn advances the age of diagnosis of PD, consistent with the theory that exposure to Mn adds to the natural loss of neurons attributable to the aging process.
pA  
A01 01  1    @0 0013-9351
A02 01      @0 ENVRAL
A03   1    @0 Environ. res. : (N.Y. N.Y. : Print)
A05       @2 104
A06       @2 3
A08 01  1  ENG  @1 A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities
A11 01  1    @1 FINKELSTEIN (Murray M.)
A11 02  1    @1 JERRETT (Michael)
A14 01      @1 McMaster University and University of Toronto @3 CAN @Z 1 aut.
A14 02      @1 University of California @2 Berkeley @3 USA @Z 2 aut.
A20       @1 420-432
A21       @1 2007
A23 01      @0 ENG
A43 01      @1 INIST @2 13896 @5 354000162834500130
A44       @0 0000 @1 © 2007 INIST-CNRS. All rights reserved.
A45       @0 1 p.
A47 01  1    @0 07-0357748
A60       @1 P
A61       @0 A
A64 01  1    @0 Environmental research : (New York, N.Y. : Print)
A66 01      @0 USA
C01 01    ENG  @0 There is concern that industrial emissions of manganese (Mn) and the use of Mn-containing compounds as fuel additives might increase the population risk of Parkinson's disease (PD)-like disorders. We investigated associations between the diagnosis and treatment of PD and markers of exposure to vehicle exhaust and industrial emissions of Mn within a cohort of 110,000 subjects in the cities of Toronto and Hamilton, Canada. Methylcyclopentadienyl manganese tricarbonyl (MMT) has been added to Canadian gasoline since 1976 and steelmaking in Hamilton emits Mn to the air. Using residential postal codes, subjects were mapped to: (1) residence locations close to traffic and to neighbourhood levels of NO2, as markers of traffic-generated air pollution (TGAP); and, (2) neighbourhood levels of ambient Mn in Hamilton, as measured by the Mn fraction of total suspended particulate. Subjects were linked to Ministry of Health administrative databases, 1992-1999, to identify physicians' diagnoses of PD and prescriptions for L-Dopa containing medications. In Toronto, we found no association between PD and the markers of TGAP. In Hamilton, the odds ratio for a physician's diagnosis of PD was 1.034 (1.00-1.07) per 10 ng/m3 increase in Mn in TSP. The estimate of the "doubling exposure" for physician-diagnosed PD was about 150 ng/m3 Mn in TSP. Examination of prevalence curves suggested that exposure to ambient Mn advances the age of diagnosis of PD, consistent with the theory that exposure to Mn adds to the natural loss of neurons attributable to the aging process.
C02 01  X    @0 002B17G
C02 02  X    @0 002B03M02
C02 03  X    @0 002B17A01
C02 04  X    @0 002B03L05
C03 01  X  FRE  @0 Environnement @5 02
C03 01  X  ENG  @0 Environment @5 02
C03 01  X  SPA  @0 Medio ambiente @5 02
C03 02  X  FRE  @0 Manganèse @2 NC @5 03
C03 02  X  ENG  @0 Manganese @2 NC @5 03
C03 02  X  SPA  @0 Manganeso @2 NC @5 03
C03 03  X  FRE  @0 Pollution air @5 05
C03 03  X  ENG  @0 Air pollution @5 05
C03 03  X  SPA  @0 Contaminación aire @5 05
C03 04  X  FRE  @0 Canada @2 NG @5 06
C03 04  X  ENG  @0 Canada @2 NG @5 06
C03 04  X  SPA  @0 Canadá @2 NG @5 06
C03 05  X  FRE  @0 Milieu urbain @5 08
C03 05  X  ENG  @0 Urban environment @5 08
C03 05  X  SPA  @0 Medio urbano @5 08
C03 06  X  FRE  @0 Homme @5 09
C03 06  X  ENG  @0 Human @5 09
C03 06  X  SPA  @0 Hombre @5 09
C03 07  X  FRE  @0 Parkinson maladie @5 10
C03 07  X  ENG  @0 Parkinson disease @5 10
C03 07  X  SPA  @0 Parkinson enfermedad @5 10
C03 08  X  FRE  @0 Trafic routier urbain @5 11
C03 08  X  ENG  @0 Urban road traffic @5 11
C03 08  X  SPA  @0 Tráfico vial urbano @5 11
C03 09  X  FRE  @0 Toxicité @5 12
C03 09  X  ENG  @0 Toxicity @5 12
C03 09  X  SPA  @0 Toxicidad @5 12
C03 10  X  FRE  @0 Epidémiologie @5 16
C03 10  X  ENG  @0 Epidemiology @5 16
C03 10  X  SPA  @0 Epidemiología @5 16
C03 11  X  FRE  @0 Gaz échappement @2 FX @5 17
C03 11  X  ENG  @0 Exhaust gas @2 FX @5 17
C03 11  X  SPA  @0 Gas escape @2 FX @5 17
C03 12  X  FRE  @0 Industrie @5 18
C03 12  X  ENG  @0 Industry @5 18
C03 12  X  SPA  @0 Industria @5 18
C03 13  X  FRE  @0 Santé publique @5 19
C03 13  X  ENG  @0 Public health @5 19
C03 13  X  SPA  @0 Salud pública @5 19
C07 01  X  FRE  @0 Amérique du Nord @2 NG
C07 01  X  ENG  @0 North America @2 NG
C07 01  X  SPA  @0 America del norte @2 NG
C07 02  X  FRE  @0 Amérique @2 NG
C07 02  X  ENG  @0 America @2 NG
C07 02  X  SPA  @0 America @2 NG
C07 03  X  FRE  @0 Encéphale pathologie @5 61
C07 03  X  ENG  @0 Cerebral disorder @5 61
C07 03  X  SPA  @0 Encéfalo patología @5 61
C07 04  X  FRE  @0 Extrapyramidal syndrome @5 62
C07 04  X  ENG  @0 Extrapyramidal syndrome @5 62
C07 04  X  SPA  @0 Extrapiramidal síndrome @5 62
C07 05  X  FRE  @0 Maladie dégénérative @5 63
C07 05  X  ENG  @0 Degenerative disease @5 63
C07 05  X  SPA  @0 Enfermedad degenerativa @5 63
C07 06  X  FRE  @0 Système nerveux central pathologie @5 64
C07 06  X  ENG  @0 Central nervous system disease @5 64
C07 06  X  SPA  @0 Sistema nervosio central patología @5 64
C07 07  X  FRE  @0 Système nerveux pathologie @5 65
C07 07  X  ENG  @0 Nervous system diseases @5 65
C07 07  X  SPA  @0 Sistema nervioso patología @5 65
C07 08  X  FRE  @0 Métal lourd @5 66
C07 08  X  ENG  @0 Heavy metal @5 66
C07 08  X  SPA  @0 Metal pesado @5 66
N21       @1 225

Links toward previous steps (curation, corpus...)

Links to Exploration step

Pascal:07-0357748

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities</title>
<author>
<name sortKey="Finkelstein, Murray M" sort="Finkelstein, Murray M" uniqKey="Finkelstein M" first="Murray M." last="Finkelstein">Murray M. Finkelstein</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>McMaster University and University of Toronto</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Jerrett, Michael" sort="Jerrett, Michael" uniqKey="Jerrett M" first="Michael" last="Jerrett">Michael Jerrett</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>University of California</s1>
<s2>Berkeley</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">07-0357748</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 07-0357748 INIST</idno>
<idno type="RBID">Pascal:07-0357748</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000721</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000599</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities</title>
<author>
<name sortKey="Finkelstein, Murray M" sort="Finkelstein, Murray M" uniqKey="Finkelstein M" first="Murray M." last="Finkelstein">Murray M. Finkelstein</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>McMaster University and University of Toronto</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Jerrett, Michael" sort="Jerrett, Michael" uniqKey="Jerrett M" first="Michael" last="Jerrett">Michael Jerrett</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>University of California</s1>
<s2>Berkeley</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Environmental research : (New York, N.Y. : Print)</title>
<title level="j" type="abbreviated">Environ. res. : (N.Y. N.Y. : Print)</title>
<idno type="ISSN">0013-9351</idno>
<imprint>
<date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Environmental research : (New York, N.Y. : Print)</title>
<title level="j" type="abbreviated">Environ. res. : (N.Y. N.Y. : Print)</title>
<idno type="ISSN">0013-9351</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Air pollution</term>
<term>Canada</term>
<term>Environment</term>
<term>Epidemiology</term>
<term>Exhaust gas</term>
<term>Human</term>
<term>Industry</term>
<term>Manganese</term>
<term>Parkinson disease</term>
<term>Public health</term>
<term>Toxicity</term>
<term>Urban environment</term>
<term>Urban road traffic</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Environnement</term>
<term>Manganèse</term>
<term>Pollution air</term>
<term>Canada</term>
<term>Milieu urbain</term>
<term>Homme</term>
<term>Parkinson maladie</term>
<term>Trafic routier urbain</term>
<term>Toxicité</term>
<term>Epidémiologie</term>
<term>Gaz échappement</term>
<term>Industrie</term>
<term>Santé publique</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Canada</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Manganèse</term>
<term>Homme</term>
<term>Santé publique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">There is concern that industrial emissions of manganese (Mn) and the use of Mn-containing compounds as fuel additives might increase the population risk of Parkinson's disease (PD)-like disorders. We investigated associations between the diagnosis and treatment of PD and markers of exposure to vehicle exhaust and industrial emissions of Mn within a cohort of 110,000 subjects in the cities of Toronto and Hamilton, Canada. Methylcyclopentadienyl manganese tricarbonyl (MMT) has been added to Canadian gasoline since 1976 and steelmaking in Hamilton emits Mn to the air. Using residential postal codes, subjects were mapped to: (1) residence locations close to traffic and to neighbourhood levels of NO
<sub>2</sub>
, as markers of traffic-generated air pollution (TGAP); and, (2) neighbourhood levels of ambient Mn in Hamilton, as measured by the Mn fraction of total suspended particulate. Subjects were linked to Ministry of Health administrative databases, 1992-1999, to identify physicians' diagnoses of PD and prescriptions for L-Dopa containing medications. In Toronto, we found no association between PD and the markers of TGAP. In Hamilton, the odds ratio for a physician's diagnosis of PD was 1.034 (1.00-1.07) per 10 ng/m
<sup>3</sup>
increase in Mn in TSP. The estimate of the "doubling exposure" for physician-diagnosed PD was about 150 ng/m
<sup>3</sup>
Mn in TSP. Examination of prevalence curves suggested that exposure to ambient Mn advances the age of diagnosis of PD, consistent with the theory that exposure to Mn adds to the natural loss of neurons attributable to the aging process.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0013-9351</s0>
</fA01>
<fA02 i1="01">
<s0>ENVRAL</s0>
</fA02>
<fA03 i2="1">
<s0>Environ. res. : (N.Y. N.Y. : Print)</s0>
</fA03>
<fA05>
<s2>104</s2>
</fA05>
<fA06>
<s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>FINKELSTEIN (Murray M.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>JERRETT (Michael)</s1>
</fA11>
<fA14 i1="01">
<s1>McMaster University and University of Toronto</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>University of California</s1>
<s2>Berkeley</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA20>
<s1>420-432</s1>
</fA20>
<fA21>
<s1>2007</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>13896</s2>
<s5>354000162834500130</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2007 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>1 p.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>07-0357748</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Environmental research : (New York, N.Y. : Print)</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>There is concern that industrial emissions of manganese (Mn) and the use of Mn-containing compounds as fuel additives might increase the population risk of Parkinson's disease (PD)-like disorders. We investigated associations between the diagnosis and treatment of PD and markers of exposure to vehicle exhaust and industrial emissions of Mn within a cohort of 110,000 subjects in the cities of Toronto and Hamilton, Canada. Methylcyclopentadienyl manganese tricarbonyl (MMT) has been added to Canadian gasoline since 1976 and steelmaking in Hamilton emits Mn to the air. Using residential postal codes, subjects were mapped to: (1) residence locations close to traffic and to neighbourhood levels of NO
<sub>2</sub>
, as markers of traffic-generated air pollution (TGAP); and, (2) neighbourhood levels of ambient Mn in Hamilton, as measured by the Mn fraction of total suspended particulate. Subjects were linked to Ministry of Health administrative databases, 1992-1999, to identify physicians' diagnoses of PD and prescriptions for L-Dopa containing medications. In Toronto, we found no association between PD and the markers of TGAP. In Hamilton, the odds ratio for a physician's diagnosis of PD was 1.034 (1.00-1.07) per 10 ng/m
<sup>3</sup>
increase in Mn in TSP. The estimate of the "doubling exposure" for physician-diagnosed PD was about 150 ng/m
<sup>3</sup>
Mn in TSP. Examination of prevalence curves suggested that exposure to ambient Mn advances the age of diagnosis of PD, consistent with the theory that exposure to Mn adds to the natural loss of neurons attributable to the aging process.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17G</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B03M02</s0>
</fC02>
<fC02 i1="03" i2="X">
<s0>002B17A01</s0>
</fC02>
<fC02 i1="04" i2="X">
<s0>002B03L05</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Environnement</s0>
<s5>02</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Environment</s0>
<s5>02</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Medio ambiente</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Manganèse</s0>
<s2>NC</s2>
<s5>03</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Manganese</s0>
<s2>NC</s2>
<s5>03</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Manganeso</s0>
<s2>NC</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Pollution air</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Air pollution</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Contaminación aire</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Canada</s0>
<s2>NG</s2>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Canada</s0>
<s2>NG</s2>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Canadá</s0>
<s2>NG</s2>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Milieu urbain</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Urban environment</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Medio urbano</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Homme</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Human</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Parkinson maladie</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Trafic routier urbain</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Urban road traffic</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Tráfico vial urbano</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Toxicité</s0>
<s5>12</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Toxicity</s0>
<s5>12</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Toxicidad</s0>
<s5>12</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Epidémiologie</s0>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Epidemiology</s0>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Epidemiología</s0>
<s5>16</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Gaz échappement</s0>
<s2>FX</s2>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Exhaust gas</s0>
<s2>FX</s2>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Gas escape</s0>
<s2>FX</s2>
<s5>17</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE">
<s0>Industrie</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG">
<s0>Industry</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA">
<s0>Industria</s0>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE">
<s0>Santé publique</s0>
<s5>19</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG">
<s0>Public health</s0>
<s5>19</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA">
<s0>Salud pública</s0>
<s5>19</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Amérique du Nord</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>North America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>America del norte</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Amérique</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>61</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>61</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>61</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>62</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>62</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>62</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>63</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>63</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>63</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>64</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>64</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>64</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>65</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>65</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>65</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE">
<s0>Métal lourd</s0>
<s5>66</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG">
<s0>Heavy metal</s0>
<s5>66</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA">
<s0>Metal pesado</s0>
<s5>66</s5>
</fC07>
<fN21>
<s1>225</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000599 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000599 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:07-0357748
   |texte=   A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022